Altre lingue Knight Therapeutics Inc.

Azioni

GUD

CA4990531069

Mercato chiuso - Toronto S.E. Altri mercati azionari 22:00:00 19/04/2024			Variaz. 5gg	Var. 1 gen.
5,72 ^CAD	-1,21%		-0,69%	+10,21%

22/03	KNIGHT THERAPEUTICS INC. : giudizio positivo da RBC Capital Markets	ZM
21/03	Knight Therapeutics riporta i risultati del quarto trimestre	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Knight présentera à la conférence des investisseurs en santé Bloom Burton & Co. 2024	09/04
Knight to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference	09/04
Thérapeutique Knight inc. se mérite une place à la cinquième édition du classement Women Lead Here du Globe and Mail sur la diversité des femmes cadres	28/03
Knight Therapeutics Inc. ranks on The Globe and Mail’s fifth-annual Women Lead Here benchmark of executive gender diversity	28/03
Knight Therapeutics Reports Fourth Quarter Results	21/03
Knight Therapeutics Inc. Provides Revenue Guidance for the Fiscal Year 2024	21/03
Knight Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	21/03
Knight Therapeutics Inc. Announces Impairment Charges for the Fourth Quarter of 2023	21/03
Thérapeutique Knight publie ses résultats du quatrième trimestre et de fin d'année 2023	21/03
Knight Therapeutics Reports Fourth Quarter and Year-End 2023 Results	21/03
Knight Therapeutics Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	21/03
North American Morning Briefing : Investors -2-	21/03
North American Morning Briefing : Investors Continue to Cheer Reassuring Fed	21/03
Avis de conférence téléphonique de Thérapeutique Knight sur ses résultats du quatrième trimestre et de fin d’année 2023	14/03
Notice of Knight Therapeutics' Fourth Quarter and Year End 2023 Results Conference Call	14/03
Knight Therapeutics Announces Launch of Minjuvi in Brazil	29/02
Knight Therapeutics Brief: Announcing Launch of Minjuvi in Brazil	29/02
Thérapeutique Knight annonce le lancement de Minjuvi® au Brésil	29/02
Knight Therapeutics Announces Launch of Minjuvi® in Brazil	29/02
Knight Therapeutics Announces Launch of Minjuvi® in Brazil	29/02

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Knight Therapeutics Inc.

Azioni

GUD

CA4990531069

Altre lingue

Filtri